Article ; Online: Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium.
2012 Volume 9, Issue 12, Page(s) 3495–3505
Abstract: ... reduction in magnesium absorption following 1 week of omeprazole in humans. Simulations provide insight ... by referencing literature data. Our modeling with human data reveals that magnesium absorption is substantial ... Prolonged use of proton pump inhibitors has reportedly caused rare clinically symptomatic ...
| Abstract | Prolonged use of proton pump inhibitors has reportedly caused rare clinically symptomatic hypomagnesemia. A review of the literature suggests PPI drugs may impair intestinal magnesium absorption. With the goal of preventing PPI-induced hypomagnesemia, an oral absorption-centric model was developed by referencing literature data. Our modeling with human data reveals that magnesium absorption is substantial in the distal intestine. We then perform simulations by referring to the reported reduction in mid to distal intestinal pH caused by one week of oral esomeprazole, and to reported reduction of the divalent cation-sensitive current when the carboxyl side chains of glutamic and aspartic residues in the binding channels of TRPM6/TRPM7 were neutralized. Our simulations reveal that short-term PPI therapy may cause a very small reduction (5%) in the serum magnesium level, which is qualitatively consistent with the reported 1% reduction in magnesium absorption following 1 week of omeprazole in humans. Simulations provide insight into the benefit of frequent but small dose of magnesium supplementation in maintaining the serum magnesium level when magnesium deficiency occurs. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Administration, Oral ; Computer Simulation ; Homeostasis ; Humans ; Intestinal Absorption/drug effects ; Magnesium/metabolism ; Magnesium/pharmacokinetics ; Magnesium Deficiency/drug therapy ; Magnesium Deficiency/metabolism ; Models, Biological ; Omeprazole/pharmacology ; Protein-Serine-Threonine Kinases ; Proton Pump Inhibitors/pharmacology ; TRPM Cation Channels/metabolism ; Tissue Distribution | |||||
| Chemical Substances | Proton Pump Inhibitors ; TRPM Cation Channels ; TRPM6 protein, human ; Protein-Serine-Threonine Kinases (EC 2.7.11.1) ; TRPM7 protein, human (EC 2.7.11.1) ; Magnesium (I38ZP9992A) ; Omeprazole (KG60484QX9) | |||||
| Language | English | |||||
| Publishing date | 2012-12-03 | |||||
| Publishing country | United States | |||||
| Document type | Journal Article | |||||
| ZDB-ID | 2138405-8 | |||||
| ISSN | 1543-8392 ; 1543-8384 | |||||
| ISSN (online) | 1543-8392 | |||||
| ISSN | 1543-8384 | |||||
| DOI | 10.1021/mp300323q | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6250: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.